Amneal Pharmaceuticals Reaches Analyst Target Price
January 15, 2020 at 08:21 AM EST
In recent trading, shares of Amneal Pharmaceuticals Inc (AMRX) have crossed above the average analyst 12-month target price of $4.55, changing hands for $5.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..